Page last updated: 2024-10-24

protein peptidyl-prolyl isomerization

Definition

Target type: biologicalprocess

The modification of a protein by cis-trans isomerization of a proline residue. [GOC:krc, PMID:16959570]

Protein peptidyl-prolyl isomerization is a crucial step in protein folding and function, catalyzed by peptidyl-prolyl isomerases (PPIases). This process involves the cis-trans isomerization of the peptide bond preceding proline residues, which are known for their rigid structure due to the cyclic nature of their side chain.

In its native state, proline residues often adopt the trans conformation, where the carbonyl group of the preceding residue and the nitrogen atom of the proline residue are on opposite sides of the peptide bond. However, in certain protein structures, the cis conformation, where these groups are on the same side, is required for proper folding and function.

PPIases accelerate the rate of this isomerization reaction, which can be extremely slow in the absence of an enzyme. There are two main classes of PPIases: cyclophilins, FK506-binding proteins (FKBPs), and parvulin.

The mechanism of action involves the PPIase binding to the peptide bond preceding proline, bringing the substrate into close proximity with the active site. The active site contains a conserved catalytic residue, usually a proline or a tyrosine, which interacts with the peptide bond and facilitates the isomerization.

The process is highly specific for proline residues due to the unique properties of their side chain. The cyclic structure of proline restricts the rotation around the peptide bond, leading to the formation of cis and trans conformations with distinct energetic states.

PPIases play essential roles in various cellular processes, including protein folding, signal transduction, and immune response. Defects in PPIases can contribute to various diseases, such as cancer, neurodegenerative disorders, and autoimmune diseases.

The precise role of PPIases in protein folding varies depending on the protein in question. Some proteins require cis-proline residues for proper folding, while others rely on the trans conformation. PPIases ensure that these proline residues are in the correct conformation for proper protein structure and function.'
"

Proteins (10)

ProteinDefinitionTaxonomy
Peptidyl-prolyl cis-trans isomerase FKBP1A[no definition available]Bos taurus (cattle)
Peptidyl-prolyl cis-trans isomerase FKBP1BA peptidyl-prolyl cis-trans isomerase FKBP1B that is encoded in the genome of human. [PRO:DNx, UniProtKB:P68106]Homo sapiens (human)
Peptidyl-prolyl cis-trans isomerase FKBP4A peptidyl-prolyl cis-trans isomerase FKBP4 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q02790]Homo sapiens (human)
Peptidyl-prolyl cis-trans isomerase FKBP5A peptidyl-prolyl cis-trans isomerase FKBP5 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q13451]Homo sapiens (human)
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1A peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q13526]Homo sapiens (human)
Peptidyl-prolyl cis-trans isomerase DA eukaryotic-type peptidyl-prolyl cis-trans isomerase D that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q08752]Homo sapiens (human)
Peptidyl-prolyl cis-trans isomerase FKBP1AA peptidyl-prolyl cis-trans isomerase FKBP1A that is encoded in the genome of human. [PRO:DNx, UniProtKB:P62942]Homo sapiens (human)
Peptidyl-prolyl cis-trans isomerase A A peptidyl-prolyl cis-trans isomerase A that is encoded in the genome of human. [PRO:DNx, UniProtKB:P62937]Homo sapiens (human)
Peptidyl-prolyl cis-trans isomerase F, mitochondrialA peptidyl-prolyl cis-trans isomerase F, mitochondrial that is encoded in the genome of human. [PRO:DNx, UniProtKB:P30405]Homo sapiens (human)
Peptidyl-prolyl cis-trans isomerase BA eukaryotic peptidyl-prolyl cis-trans isomerase B that is encoded in the genome of human. [PRO:DNx, UniProtKB:P23284]Homo sapiens (human)

Compounds (33)

CompoundDefinitionClassesRoles
imidazole1H-imidazole : An imidazole tautomer which has the migrating hydrogen at position 1.

imidazole: RN given refers to parent cpd
imidazole
juglonejuglone : A hydroxy-1,4-naphthoquinone that is 1,4-naphthoquinone in which the hydrogen at position 5 has been replaced by a hydroxy group. A plant-derived 1,4-naphthoquinone with confirmed antibacterial and antitumor activities.

juglone: structure
hydroxy-1,4-naphthoquinonegeroprotector;
herbicide;
reactive oxygen species generator
thiabendazoleTresaderm: dermatologic soln containing dexamethasone, thiabendazole & neomycin sulfate1,3-thiazoles;
benzimidazole fungicide;
benzimidazoles
antifungal agrochemical;
antinematodal drug
cycloheximidecycloheximide : A dicarboximide that is 4-(2-hydroxyethyl)piperidine-2,6-dione in which one of the hydrogens attached to the carbon bearing the hydroxy group is replaced by a 3,5-dimethyl-2-oxocyclohexyl group. It is an antibiotic produced by the bacterium Streptomyces griseus.

Cycloheximide: Antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus. It acts by inhibiting elongation during protein synthesis.
antibiotic fungicide;
cyclic ketone;
dicarboximide;
piperidine antibiotic;
piperidones;
secondary alcohol
anticoronaviral agent;
bacterial metabolite;
ferroptosis inhibitor;
neuroprotective agent;
protein synthesis inhibitor
1,4-naphthoquinone1,4-naphthoquinone : The parent structure of the family of 1,4-naphthoquinones, in which the oxo groups of the quinone moiety are at positions 1 and 4 of the naphthalene ring. Derivatives have pharmacological properties.

naphthoquinone : A polycyclic aromatic ketone metabolite of naphthalene.
1,4-naphthoquinones
2-hydroxypyridinehydroxypyridine : Any member of the class of pyridines with at least one hydroxy substituent.

pyridin-2-ol : A monohydroxypyridine that is pyridine substituted by a hydroxy group at position 2.
monohydroxypyridineplant metabolite
glycyrrhetinic acidcyclic terpene ketone;
hydroxy monocarboxylic acid;
pentacyclic triterpenoid
immunomodulator;
plant metabolite
2,4-pyridinedicarboxylic acidlutidinic acid : A pyridinedicarboxylic acid carrying carboxy groups at positions 2 and 4.pyridinedicarboxylic acid
2-piperidone2-piperidone: structure given in first source

piperidin-2-one : A delta-lactam that is piperidine which is substituted by an oxo group at position 2.
delta-lactam;
piperidones
EC 1.2.1.88 (L-glutamate gamma-semialdehyde dehydrogenase) inhibitor
4-methylimidazole4-methylimidazole : Imidazole substituted at position 4 by a methyl group.

4-methylimidazole: RN given refers to parent cpd
imidazolescarcinogenic agent;
reaction intermediate
daminozidedaminozide: induces tumorsstraight-chain fatty acid
epigallocatechin gallate(-)-epigallocatechin 3-gallate : A gallate ester obtained by the formal condensation of gallic acid with the (3R)-hydroxy group of (-)-epigallocatechin.

epigallocatechin gallate: a steroid 5alpha-reductase inhibitor and antimutagen in green tea (Camellia sinensis)
flavans;
gallate ester;
polyphenol
antineoplastic agent;
antioxidant;
apoptosis inducer;
geroprotector;
Hsp90 inhibitor;
neuroprotective agent;
plant metabolite
propazolepropazole: RN given refers to parent cpd; structurebenzimidazoles
prolinalpyrrolidines
tretinoinall-trans-retinoic acid : A retinoic acid in which all four exocyclic double bonds have E- (trans-) geometry.

retinoic acid : A retinoid consisting of 3,7-dimethylnona-2,4,6,8-tetraenoic acid substituted at position 9 by a 2,6,6-trimethylcyclohex-1-en-1-yl group (geometry of the four exocyclic double bonds is not specified).

Tretinoin: An important regulator of GENE EXPRESSION during growth and development, and in NEOPLASMS. Tretinoin, also known as retinoic acid and derived from maternal VITAMIN A, is essential for normal GROWTH; and EMBRYONIC DEVELOPMENT. An excess of tretinoin can be teratogenic. It is used in the treatment of PSORIASIS; ACNE VULGARIS; and several other SKIN DISEASES. It has also been approved for use in promyelocytic leukemia (LEUKEMIA, PROMYELOCYTIC, ACUTE).
retinoic acid;
vitamin A
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
AP-1 antagonist;
human metabolite;
keratolytic drug;
retinoic acid receptor agonist;
retinoid X receptor agonist;
signalling molecule
3-(3-pyridyl)-1-propyl-(2s)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-pyrrolidinecarboxylate
tacrolimustacrolimus (anhydrous) : A macrolide lactam containing a 23-membered lactone ring, originally isolated from the fermentation broth of a Japanese soil sample that contained the bacteria Streptomyces tsukubaensis.

Tacrolimus: A macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis that has strong immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation in vitro.
macrolide lactambacterial metabolite;
immunosuppressive agent
N-(2-fluorophenyl)-2-[2-(4-thiazolyl)-1-benzimidazolyl]acetamidebenzimidazoles
biricodarbiricodar: a non-macrocyclic ligand for FKBP12; structure in first sourcealpha-amino acid ester
oxalylglycineN-oxalylglycine : An amino dicarboxylic acid that is iminodiacetic acid with an oxo substituent. It is used as an inhibitor of alpha-ketoglutarate dependent (EC 1.14.11.*) enzymes.

oxalylglycine: structure given in first source
amino dicarboxylic acid;
N-acylglycine
EC 1.14.11.* (oxidoreductase acting on paired donors, 2-oxoglutarate as one donor, incorporating 1 atom each of oxygen into both donors) inhibitor
pd 407824
l 683590immunomycin: from Streptomyces hygroscopicus; structure given in first sourceether;
lactol;
macrolide;
secondary alcohol
antifungal agent;
bacterial metabolite;
immunosuppressive agent
cyclosporineramihyphin A: one of the metabolites produced by Fusarium sp. S-435; RN given refers to cpd with unknown MFhomodetic cyclic peptideanti-asthmatic drug;
anticoronaviral agent;
antifungal agent;
antirheumatic drug;
carcinogenic agent;
dermatologic drug;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
geroprotector;
immunosuppressive agent;
metabolite
sirolimussirolimus : A macrolide lactam isolated from Streptomyces hygroscopicus consisting of a 29-membered ring containing 4 trans double bonds, three of which are conjugated. It is an antibiotic, immunosupressive and antineoplastic agent.

Sirolimus: A macrolide compound obtained from Streptomyces hygroscopicus that acts by selectively blocking the transcriptional activation of cytokines thereby inhibiting cytokine production. It is bioactive only when bound to IMMUNOPHILINS. Sirolimus is a potent immunosuppressant and possesses both antifungal and antineoplastic properties.
antibiotic antifungal drug;
cyclic acetal;
cyclic ketone;
ether;
macrolide lactam;
organic heterotricyclic compound;
secondary alcohol
antibacterial drug;
anticoronaviral agent;
antineoplastic agent;
bacterial metabolite;
geroprotector;
immunosuppressive agent;
mTOR inhibitor
sanglifehrin asanglifehrin A: binds cyclophilin A; isolated from Streptomyces; structure in first source
(melle-4)cyclosporin(melle-4)cyclosporin: a non-immunosuppressive analog of cyclosporin A
cyclosporin gcyclosporin G: similar immunosuppressive actions as cyclosporin, but without nephrotoxic side effects; cyclosporin A analog; MW 1217
scy-635
bastadin 5
timcodartimcodar: a mutlidrug resistance inhibitor; structure in first source
acetyl-11-ketoboswellic acidacetyl-11-ketoboswellic acid: a 5-lipoxygenase inhibitor; structure given in first sourcetriterpenoid
nutlin-3anutlin 3: an MDM2 antagonist; structure in first sourcestilbenoid
alisporiviralisporivir: nonimmunosuppressive cyclosporin analog; structure/sequence in first sourcehomodetic cyclic peptideanticoronaviral agent